149 related articles for article (PubMed ID: 16160012)
1. ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications.
Chiaretti S; Guarini A; De Propris MS; Tavolaro S; Intoppa S; Vitale A; Iacobelli S; Elia L; Ariola C; Ritz J; Foà R
Blood; 2006 Jan; 107(1):197-204. PubMed ID: 16160012
[TBL] [Abstract][Full Text] [Related]
2. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X
Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861
[TBL] [Abstract][Full Text] [Related]
3. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
[TBL] [Abstract][Full Text] [Related]
4. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
[TBL] [Abstract][Full Text] [Related]
6. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients.
Jiménez-Morales S; Miranda-Peralta E; Saldaña-Alvarez Y; Perez-Vera P; Paredes-Aguilera R; Rivera-Luna R; Velázquez-Cruz R; Ramírez-Bello J; Carnevale A; Orozco L
Leuk Res; 2008 Oct; 32(10):1518-22. PubMed ID: 18455790
[TBL] [Abstract][Full Text] [Related]
7. Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative.
Gaynon PS; Crotty ML; Sather HN; Bostrom BC; Nachman JB; Steinherz PG; Heerema NA; Sarquis M; Tuel-Ahlgren L; Uckun FM
Leuk Lymphoma; 1997 Jun; 26(1-2):57-65. PubMed ID: 9250788
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of molecular screening in childhood lymphoblastic leukemias].
Anguita E; González FA; Contra T; Martín N; Valverde F; Villegas A
Sangre (Barc); 1998 Feb; 43(1):7-11. PubMed ID: 9577176
[TBL] [Abstract][Full Text] [Related]
9. [Real-time quantitative detection of E2A-PBX1 fusion gene in children with acute lymphoblastic leukemia and its clinical application in minimal residual disease monitoring].
Zhang R; Liao J; Li G; Sun HQ; Shi YJ; Yang JY
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):440-3. PubMed ID: 23791058
[TBL] [Abstract][Full Text] [Related]
10. E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.
Duque-Afonso J; Lin CH; Han K; Wei MC; Feng J; Kurzer JH; Schneidawind C; Wong SH; Bassik MC; Cleary ML
Cancer Res; 2016 Dec; 76(23):6937-6949. PubMed ID: 27758892
[TBL] [Abstract][Full Text] [Related]
11. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.
Wiemels JL; Leonard BC; Wang Y; Segal MR; Hunger SP; Smith MT; Crouse V; Ma X; Buffler PA; Pine SR
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15101-6. PubMed ID: 12415113
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
Chiaretti S; Li X; Gentleman R; Vitale A; Wang KS; Mandelli F; Foà R; Ritz J
Clin Cancer Res; 2005 Oct; 11(20):7209-19. PubMed ID: 16243790
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility.
Sang BC; Shi L; Dias P; Liu L; Wei J; Wang ZX; Monell CR; Behm F; Gruenwald S
Blood; 1997 Apr; 89(8):2909-14. PubMed ID: 9108411
[TBL] [Abstract][Full Text] [Related]
14. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
15. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia.
Privitera E; Kamps MP; Hayashi Y; Inaba T; Shapiro LH; Raimondi SC; Behm F; Hendershot L; Carroll AJ; Baltimore D
Blood; 1992 Apr; 79(7):1781-8. PubMed ID: 1348433
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.
McWhirter JR; Neuteboom ST; Wancewicz EV; Monia BP; Downing JR; Murre C
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11464-9. PubMed ID: 10500199
[TBL] [Abstract][Full Text] [Related]
17. [Childhood acute lymphoblastic leukemia with t(1;19) lacking E2A-pBX1 chimeric transcripts].
Matsubara K; Hirata T
Rinsho Ketsueki; 2005 Jan; 46(1):7-12. PubMed ID: 16708911
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia].
Gao C; Li ZG; Zhao W; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):569-73. PubMed ID: 18549631
[TBL] [Abstract][Full Text] [Related]
19. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
20. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
